Mainstreaming the Microbiome – Part 2
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In mid-April I noted the quickening pace of commercial investment in microbiome translational research and made what now seems like a paltry prediction to the effect that: “the […]
